Get started
Pharming Group NVPharming Group NVPharming Group NV

Pharming Group NV

No trades
See on Supercharts
OverviewFinancialsNewsIdeasMindsTechnicalsForecastsSeasonalsBondsETFs

Chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪897.58 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.01 USD
Net income (FY)
‪−11.33 M‬ USD
Revenue (FY)
‪284.43 M‬ USD
Shares float
‪669.58 M‬
Beta (1Y)
1.25

About Pharming Group NV


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Fabrice Chouraqui
Website
pharming.com
Headquarters
Leiden
Founded
1988
ISIN
NL0010391025
FIGI
BBG000G4B509
Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following segments: RUCONEST®, Joenja®, Europe, and Rest of the World. The company was founded on November 11, 1988, and is headquartered in Leiden, the Netherlands.

Check out other big names from the same industry as PHGUF.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Highest yielding bonds


XS276301888
Pharming Group N.V. 4.5% 25-APR-2029
Yield to maturity
—
Maturity date
Apr 25, 2029

See all PHGUF bonds 

ETFs


EL4D
Deka STOXX Europe Strong Value 20 UCITS ETF
Weight
4.72%
Market value
‪2.71 M‬
USD
XXSC
Xtrackers MSCI Europe Small Cap UCITS ETF Capitalisation 1C
Weight
0.06%
Market value
‪1.77 M‬
USD
CSEMUS.EUR
iShares MSCI EMU Small Cap UCITS ETF
Weight
0.15%
Market value
‪1.54 M‬
USD
2B78
iShares Healthcare Innovation UCITS ETF
Weight
0.11%
Market value
‪1.12 M‬
USD
EMUSC.EUR
UBS (Lux) Fund Solutions SICAV - UBS MSCI EMU Small Cap UCITS ETF EUR acc- Capitalisation
Weight
0.16%
Market value
‪1.09 M‬
USD
UEFD
UBS (Lux) Fund Solutions SICAV - UBS MSCI EMU Small Cap UCITS ETF EUR dis- Distribution
Weight
0.16%
Market value
‪1.09 M‬
USD
EL4E
Deka STOXX Europe Strong Style Composite 40 UCITS ETF
Weight
2.36%
Market value
‪1.05 M‬
USD
EWN
iShares MSCI Netherlands ETF
Weight
0.33%
Market value
‪955.38 K‬
USD
GWX
SPDR S&P International Small Cap ETF
Weight
0.07%
Market value
‪567.90 K‬
USD
IEUR
iShares Core MSCI Europe ETF
Weight
0.01%
Market value
‪557.77 K‬
USD
BIGT
L&G Pharma Breakthrough UCITS ETF
Weight
2.18%
Market value
‪389.74 K‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of PHGUF is 1.20 USD — it has decreased by −20.00% in the past 24 hours. Watch Pharming Group NV stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Pharming Group NV stocks are traded under the ticker PHGUF.
PHGUF stock has fallen by −20.00% compared to the previous week, the month change is a −20.00% fall, over the last year Pharming Group NV has showed a 45.88% increase.
We've gathered analysts' opinions on Pharming Group NV future price: according to them, PHGUF price has a max estimate of 4.10 USD and a min estimate of 1.61 USD. Watch PHGUF chart and read a more detailed Pharming Group NV stock forecast: see what analysts think of Pharming Group NV and suggest that you do with its stocks.
PHGUF reached its all-time high on Oct 13, 2000 with the price of 11.50 USD, and its all-time low was 0.01 USD and was reached on Oct 1, 2012. View more price dynamics on PHGUF chart.
See other stocks reaching their highest and lowest prices.
PHGUF stock is 25.00% volatile and has beta coefficient of 1.25. Track Pharming Group NV stock price on the chart and check out the list of the most volatile stocks — is Pharming Group NV there?
Today Pharming Group NV has the market capitalization of ‪866.86 M‬, it has decreased by −5.22% over the last week.
Yes, you can track Pharming Group NV financials in yearly and quarterly reports right on TradingView.
Pharming Group NV is going to release the next earnings report on Mar 12, 2026. Keep track of upcoming events with our Earnings Calendar.
PHGUF earnings for the last quarter are 0.01 USD per share, whereas the estimation was 0.00 USD resulting in a ‪2.12 K‬% surprise. The estimated earnings for the next quarter are 0.00 USD per share. See more details about Pharming Group NV earnings.
Pharming Group NV revenue for the last quarter amounts to ‪97.30 M‬ USD, despite the estimated figure of ‪98.22 M‬ USD. In the next quarter, revenue is expected to reach ‪96.43 M‬ USD.
PHGUF net income for the last quarter is ‪4.78 M‬ USD, while the quarter before that showed ‪−15.13 M‬ USD of net income which accounts for 131.57% change. Track more Pharming Group NV financial stats to get the full picture.
No, PHGUF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Pharming Group NV EBITDA is ‪34.39 M‬ USD, and current EBITDA margin is 2.48%. See more stats in Pharming Group NV financial statements.
Like other stocks, PHGUF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Pharming Group NV stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Pharming Group NV technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Pharming Group NV stock shows the buy signal. See more of Pharming Group NV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.